Heron Therapeutics, Inc. (HRTX)
0.39
-0.03
(-6.16%)
USD |
NASDAQ |
Oct 13, 12:33
Heron Therapeutics Free Cash Flow (Quarterly) : -2.351M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.351M |
| March 31, 2026 | -1.931M |
| December 31, 2025 | -9.184M |
| September 30, 2025 | 1.331M |
| June 30, 2025 | -11.08M |
| March 31, 2025 | -8.979M |
| December 31, 2024 | -12.42M |
| September 30, 2024 | 2.94M |
| June 30, 2024 | -5.241M |
| March 31, 2024 | -9.516M |
| December 31, 2023 | 2.205M |
| September 30, 2023 | -9.972M |
| June 30, 2023 | -27.44M |
| March 31, 2023 | -25.12M |
| December 31, 2022 | -37.95M |
| September 30, 2022 | -37.11M |
| June 30, 2022 | -28.70M |
| March 31, 2022 | -44.98M |
| December 31, 2021 | -45.65M |
| September 30, 2021 | -54.70M |
| June 30, 2021 | -63.31M |
| March 31, 2021 | -42.72M |
| December 31, 2020 | -55.05M |
| September 30, 2020 | -42.69M |
| June 30, 2020 | -58.03M |
| Date | Value |
|---|---|
| March 31, 2020 | -35.87M |
| December 31, 2019 | -30.88M |
| September 30, 2019 | -24.42M |
| June 30, 2019 | -25.27M |
| March 31, 2019 | -51.16M |
| December 31, 2018 | -36.96M |
| September 30, 2018 | -39.33M |
| June 30, 2018 | -62.06M |
| March 31, 2018 | -62.62M |
| December 31, 2017 | -48.28M |
| September 30, 2017 | -40.54M |
| June 30, 2017 | -32.52M |
| March 31, 2017 | -51.52M |
| December 31, 2016 | -39.21M |
| September 30, 2016 | -36.65M |
| June 30, 2016 | -28.19M |
| March 31, 2016 | -33.18M |
| December 31, 2015 | -23.45M |
| September 30, 2015 | -20.14M |
| June 30, 2015 | -16.02M |
| March 31, 2015 | -20.00M |
| December 31, 2014 | -13.88M |
| September 30, 2014 | -19.32M |
| June 30, 2014 | -12.75M |
| March 31, 2014 | -15.77M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -42.44M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |
| Anika Therapeutics, Inc. | -2.133M |
| Savara, Inc. | -29.97M |